Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration - PubMed

Figures

Similar articles

• Colistin methanesulfonate and colistin pharmacokinetics in critically ill patients receiving continuous venovenous hemodiafiltration.

  Karvanen M, Plachouras D, Friberg LE, Paramythiotou E, Papadomichelakis E, Karaiskos I, Tsangaris I, Armaganidis A, Cars O, Giamarellou H. Karvanen M, et al. Antimicrob Agents Chemother. 2013 Jan;57(1):668-71. doi: 10.1128/AAC.00985-12. Epub 2012 Nov 12. Antimicrob Agents Chemother. 2013. PMID: 23147733 Free PMC article.

• Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study.

  Markou N, Fousteri M, Markantonis SL, Zidianakis B, Hroni D, Boutzouka E, Baltopoulos G. Markou N, et al. J Antimicrob Chemother. 2012 Oct;67(10):2459-62. doi: 10.1093/jac/dks257. Epub 2012 Jul 12. J Antimicrob Chemother. 2012. PMID: 22790220

• Determination by LC-MS/MS of colistins A and B in plasma and ultrafiltrate from critically ill patients undergoing continuous venovenous hemodiafiltration.

  Leporati M, Bua RO, Mariano F, Carignano P, Stella M, Biancone L, Vincenti M. Leporati M, et al. Ther Drug Monit. 2014 Apr;36(2):182-91. doi: 10.1097/FTD.0b013e3182a8997c. Ther Drug Monit. 2014. PMID: 24216535

• Pharmacokinetic evaluation of colistin sodium.

  Michalopoulos AS, Karatza DC, Gregorakos L. Michalopoulos AS, et al. Expert Opin Drug Metab Toxicol. 2011 Feb;7(2):245-55. doi: 10.1517/17425255.2011.541439. Epub 2010 Dec 4. Expert Opin Drug Metab Toxicol. 2011. PMID: 21128824 Review.

• [Shedding light on the use of colistin: still gaps to be filled].

  Luque S, Grau S, Berenguer N, Horcajada JP, Sorlí L, Montero MM, Salas E. Luque S, et al. Enferm Infecc Microbiol Clin. 2011 Apr;29(4):287-96. doi: 10.1016/j.eimc.2011.02.003. Enferm Infecc Microbiol Clin. 2011. PMID: 21440335 Review. Spanish.

Cited by

• Treatment Strategies of Colistin Resistance Acinetobacter baumannii Infections.

  Papazachariou A, Tziolos RN, Karakonstantis S, Ioannou P, Samonis G, Kofteridis DP. Papazachariou A, et al. Antibiotics (Basel). 2024 May 6;13(5):423. doi: 10.3390/antibiotics13050423. Antibiotics (Basel). 2024. PMID: 38786151 Free PMC article. Review.

• ^99mTc-Labeled, Colistin Encapsulated, Theranostic Liposomes for Pseudomonas aeruginosa Infection.

  Karpuz M, Temel A, Ozgenc E, Tekintas Y, Erel-Akbaba G, Senyigit Z, Atlihan-Gundogdu E. Karpuz M, et al. AAPS PharmSciTech. 2023 Mar 10;24(3):77. doi: 10.1208/s12249-023-02533-8. AAPS PharmSciTech. 2023. PMID: 36899198

• Anti-infective Medicines Use in Children and Neonates With Pre-existing Kidney Dysfunction: A Systematic Review.

  Minotti C, Barbieri E, Doni D, Impieri C, Giaquinto C, Donà D. Minotti C, et al. Front Pediatr. 2022 Apr 26;10:868513. doi: 10.3389/fped.2022.868513. eCollection 2022. Front Pediatr. 2022. PMID: 35558367 Free PMC article.

• Dose Optimization of Colistin: A Systematic Review.

  Haseeb A, Faidah HS, Alghamdi S, Alotaibi AF, Elrggal ME, Mahrous AJ, Almarzoky Abuhussain SS, Obaid NA, Algethamy M, AlQarni A, Khogeer AA, Saleem Z, Sheikh A. Haseeb A, et al. Antibiotics (Basel). 2021 Nov 26;10(12):1454. doi: 10.3390/antibiotics10121454. Antibiotics (Basel). 2021. PMID: 34943666 Free PMC article. Review.

• Rescuing the Last-Line Polymyxins: Achievements and Challenges.

  Nang SC, Azad MAK, Velkov T, Zhou QT, Li J. Nang SC, et al. Pharmacol Rev. 2021 Apr;73(2):679-728. doi: 10.1124/pharmrev.120.000020. Pharmacol Rev. 2021. PMID: 33627412 Free PMC article. Review.

References

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central